Huaxia Yingtai: Funding, Investors & Team (Oct 2026)
Huaxia Yingtai is a small molecule innovative drug R&D company developing immune cell therapy technologies and products.
Huaxia Yingtai has raised $29.4M across 1 funding round on record, the most recent a Series C of $29.4M announced in Jul 2026.
That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.
Huaxia Yingtai Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Huaxia Yingtai Funding Rounds
Huaxia Yingtai Investors
6 investors are recorded in total; the 5 named above are those the record identifies.
Huaxia Yingtai Funding in Context
Huaxia Yingtai's latest round of $29.4M is above the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Huaxia Yingtai in Biopharma and Changping
Companies Similar to Huaxia Yingtai
Lingsheng Technology is a robot developer firm that specialises in developing embodied intelligent robots.
Moonshot AI is an artificial intelligence company that develops large language models, multimodal AI systems,…
Sukos focuses. on semiconductor core equipment, providing integrated R&D, manufacturing, sales, and service…
Haoxinqing is an online medical service platform focusing on the fields of mental psychology and chronic…
Leadsynbio is a leading supplier of APIs, Human & Animal Nutrition ingredients. Innovative synthetic biology…
Sudu Technology is a high-tech enterprise specializing in the research and development of general-purpose…
Zhongke lon engages in manufacturing high-end medical devices such as proton therapy equipment.
MaxSense Technology is an autonomous driving and industrial operation optimization developer company.
Sleptay is an innovative biopharmaceutical company, developing next-generation therapies for central nervous…
Xunjie Guangyuan operates engages in the research and development of near-infrared spectroscopy analysis…
Juxie Intelligent is an intelligent technology company that specializes in the development and production of…
Xige Estate operates a wine estate that has more than 30,000 acres of its own vineyards.
Huaxia Yingtai Funding FAQs
What does Huaxia Yingtai do?
Huaxia Yingtai is a small molecule innovative drug R&D company developing immune cell therapy technologies and products.
How much funding has Huaxia Yingtai raised?
Huaxia Yingtai has raised $29.4M across 1 round on record. The most recent is a Series C of $29.4M announced in Jul 2026.
When did Huaxia Yingtai last raise funding?
Huaxia Yingtai's most recent funding round on record is a Series C of $29.4M, announced in Jul 2026.
Who has invested in Huaxia Yingtai?
Investors on record for Huaxia Yingtai include Tsinghua Holdings Capital, Loyal Valley Capital, Vertex Ventures China, Fudan Science and Technology Innovation Fund, Lotus Lake Ventures. FundedIQ records 6 investors in total.
Where is Huaxia Yingtai headquartered?
Huaxia Yingtai is based in Changping, China.
How many employees does Huaxia Yingtai have?
Huaxia Yingtai is in the 101-250 employee band.
When was Huaxia Yingtai founded?
Huaxia Yingtai was founded in 2018.
About FundedIQ's Huaxia Yingtai Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Huaxia Yingtai is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.